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Abstract—Brain dysfunction is a frequent complication of
the systemic inflammatory response to bacterial infection
or sepsis. In the present work, the eﬀects of intravenous
bacterial lipopolysaccharide (LPS) administration on cere-
bral arterial blood flow were assessed with time-of-flight
(TOF)-based magnetic resonance angiography (MRA) in
mice. Cerebral expression of the transcription factors
nuclear factor-kappaB (NF-jB) and c-Fos and that of
enzymes synthesizing vasoactive mediators, such as pros-
taglandins and nitric oxide, known to be increased under
inflammatory conditions, were studied in the same animals.
Time-resolved TOF MRA revealed no diﬀerences in blood
flow in the internal carotids upstream of the circle of Willis,
but indicated lower flow in its lateral parts as well as in the
middle and anterior cerebral arteries after intravenous LPS
injection as compared to saline administration. Although
LPS did not increase c-Fos expression in ventral forebrain
structures of these animals, it did induce NF-jB in
meningeal blood vessels. LPS also increased cerebral
expression of cyclooxygenase-2 and prostaglandin E syn-
thase mRNAs, but de novo expression occurred in veins
rather than in arteries. In conclusion, our work indicates that
LPS-induced systemic inflammation does not necessarily
aﬀect filling of the circle of the Willis from the periphery,
but that circulating LPS alters outflow from the circle of
Willis to the middle and anterior cerebral arteries. These
modifications in arterial flow were not related to increased
cerebral synthesis of prostaglandins, but may instead be
the consequence of the action of circulating prostaglandins
and other vasoactive mediators on brain-irrigating arteries
during systemic inflammation. ! 2017 IBRO. Published by
Elsevier Ltd. All rights reserved.
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INTRODUCTION
Sepsis has long been recognized to be associated with
nervous system dysfunction (Levy et al., 2003; Baron
et al., 2006). Indeed, altered mental status is present in
about a quarter of sepsis patients (Sprung et al., 1990)
and can even occur before other signs (Ebersoldt et al.,
2007). Moreover, sepsis-associated encephalopathy, for
diﬀuse or multifocal cerebral dysfunction, ranging from
lethargy to coma, is present in 70% of patients with bac-
teremia (Wilson and Young, 2003). Finally, severe sepsis
survivors often develop long-term cognitive impairments
and behavioral problems and experience a reduction in
quality of life comparable to that seen after a heart attack
(Heyland et al., 2000; Iwashyna et al., 2010; Lazosky
et al., 2010; Pandharipande et al., 2013).
Given that the brain is highly dependent on blood
supply to function properly (Rolfe and Brown, 1997) and
that sepsis comes with a high risk of organ hypoperfusion
(Jones and Puskarich, 2009), it is likely that sepsis-
associated encephalopathy is related to reduced cerebral
blood flow. Septic patients with encephalopathy do indeed
show a reduction in global cerebral blood flow compared
to healthy controls (Bowton et al., 1989; Maekawa et al.,
1991). Interestingly, this finding can be reproduced by
intravenous administration of bacterial lipopolysaccha-
rides (LPS) in human volunteers (Moller et al., 2002).
However, the techniques used in these initial studies did
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not allow for determination where the reduction in flow
occurred in the cerebral blood supply. More recent clinical
studies have applied time-of-flight (TOF) magnetic reso-
nance angiography (MRA) to sepsis-associated
encephalopathy and shown anatomical signs of vasos-
pasms in branches of the anterior and middle cerebral
arteries (ACA and MCA) (Bartynski et al., 2006; Polito
et al., 2013). In addition, flow speed in the territory of
the MCA, as measured with transcranial Doppler, has
been shown to be reduced after iv LPS administration in
healthy volunteers (Brassard et al., 2012). These findings
indicate that vasoconstrictive mechanisms in brain-
supplying arteries may reduce cerebral blood flow during
sepsis.
In the present work, we set out to better understand
sepsis-associated changes in cerebral arterial blood-
supply by trying to model these in animals. Time-
resolved 3D TOF MRA was used to functionally
characterize the high-flow systems of the circle of Willis,
ACA and MCA during systemic inflammation after
intravenous administration of bacterial LPS in mice. In
animals, prostaglandins, nitric oxide and endothelin-1
(ET-1) have been shown to be vasoactive molecules in
brain arteries and arterioles (Toda et al., 1988; Faraci
and Brian, 1994; Salom et al., 1995; Davidge, 2001;
Jadhav et al., 2004; Dabertrand et al., 2013). Interest-
ingly, in vitro rodent cerebral arteries rapidly respond to
LPS by increasing the expression of cyclooxygenase-2
(COX-2), the rate-limiting enzyme in prostaglandin syn-
thesis (Hernanz et al., 2004). Moreover, systemic admin-
istration of bacterial LPS or pro-inflammatory cytokines
increases cerebral expression of the prostaglandin-
synthesizing enzymes COX-2 and microsomal prosta-
glandin E synthase (mPGES) as well as that of inducible
nitric oxide synthase (iNOS) and ET-1 in rodents (Wong
et al., 1996; Elmquist et al., 1997; Konsman et al.,
1999, 2004; Ek et al., 2001; Yamagata et al., 2001;
Shimojo et al., 2006; Eskilsson et al., 2014). Since
increased expression of these molecules involves nuclear
factor-kappaB (NF-jB) (D’Acquisto et al., 1997; Abate
et al., 1998; Zhao et al., 2001; Wort et al., 2009), we set
out to study expression of this transcription factor in addi-
tion to that of the more general cellular activation marker
c-Fos, COX-2, mPGES, iNOS and ET-1 in the brains of
animals that underwent MRA as a first approach to deter-
mine potential mechanisms underlying sepsis-related
changes in cerebral blood flow.
EXPERIMENTAL PROCEDURES
Animals
Experiments were conducted according to European
recommendations on animal research (European
Council Directive of 24 November 1986 (86/609/EEC)
and European Parliament and Council Directive of 22
September 2010 (2010/63/UE)) and approved by the
local committee for animal experimentation (AS-SNC-
DEV Dir1434). After arrival, 20 male 3- month-old C57/
Bl6 (Charles River, Arbresle, France) were allowed at
least one week of acclimation in group cages with
ad libitum access to food and water in a temperature
(22 "C± 1 "C)-controlled environment where lights were
on from 08:00 to 20:00 h.
Magnetic resonance imaging
On the day of experiment, mice were removed from their
cage, anesthetized with 1.5–2.0% isoflurane and an
intravenous catheter placed into their caudal tail vein.
This catheter was connected to a syringe containing
either LPS or saline. Under continued anesthesia, mice
were then placed in a 4.7 T horizontal magnet (Bruker,
Ettlingen, Germany) equipped with a 6-cm BG6 gradient
system capable of generating 950 mT/m maximum
strength and an 80-ls rise time. During imaging,
respiratory rate was monitored and maintained between
80 and 100 breaths per minute and body temperature
sustained by warm water circulating in the machine’s
gradients.
Time-resolved 3D MRA
Blood flow in internal carotids, the circle of Willis and the
first segments of the ACA and MCA was assessed using
a slightly modified bright blood time-resolved 3D MRA
sequence previously developed and validated for the
mouse carotid system (Miraux et al., 2006). It covered fill-
ing of the circle of Willis and the ACA and MCA by arterial
blood in 8 images spanning 64 ms with a field of view of
2.0 ! 1.6 ! 1.4 cm and a matrix of 128 ! 80 ! 48 voxels,
thus yielding a spatial resolution of 156 ! 200 ! 292 lm.
The sequence was applied once before intravenous injec-
tion and repeated 6 times over time thereafter. Subtrac-
tion operations between the images covering 64 ms
were performed in IGOR Pro 6.04 (Wavemetrics, Lake
Oswego, OR, USA) to yield the number of voxels that
have appeared in a given interval as a measure of the
blood volume that has filled diﬀerent arterial segments
over time. After application of a fixed intensity threshold,
the values obtained in the subtracted images after intra-
venous injection were divided by those measured in
equivalent subtracted and thresholded images of the
same animal before treatment (baseline). Thus, time-
resolved 3D MRA assesses flow during a ‘‘time interval
of interest” rather than in a ‘‘region of interest”, even
though one can determine a posteriori which arterial seg-
ments were filled during the interval in question.
3D MRA
In addition to time-resolved 3D MRA to assess flow in the
circle of Willis as well as in the ACA and MCA, a 3D MRA
sequence on coronal slices with a field of view of
2.0 ! 1.6 ! 1.4 cm and a matrix of 128 ! 96 ! 64
voxels, thus yielding a spatial resolution of
156 ! 167 ! 219 lm, was used to estimate flow in the
internal carotids, ACA and MCA as well as in some of
its major branches. This MRA sequence was alternated
with time-resolved 3D MRA, applied once before
intravenous injection and repeated 7 times over time
thereafter. The coronal orientation was chosen to
maximize the axial ‘‘entrance eﬀect” of fresh blood as
the direction of flow in the arteries of interest is often
horizontal. The bright appearance of blood allowed for
identification of a fixed internal reference position slice.
Regions of interests (ROIs) centered on the internal
carotid arteries, ACA, MCA, pericallosal azygos artery
and anterior amygdaloid arteries were then placed on
more anterior or posterior slices relative to the reference
slice. Sizes of these ROIs varied from 4 voxels for the
smallest artery, the pericallosal azygos artery, to 9–10
voxels for the largest arteries, the internal carotids. The
mean intensity of voxels in each artery was measured in
Image J (http://rsbweb.nih.gov/ij/) and expressed relative
to the mean intensity to a ROI of the same form and
surface placed in a corner of the same image but
outside the head (background). The resulting blood flow
proxies after intravenous injection were expressed
relative to that in the same ROIs of the same animal
before treatment (baseline). Thus, this 3D MRA
sequence allows for a ‘‘region of interest” approach, but
at the expense of being able to compare diﬀerent ‘‘time
intervals of interest” to assess blood flow, even though
the intensity of gray levels contains this information to
some extent. As such it is comparable to the MRA
sequences routinely used in the clinic and
complementary to the time-resolved 3D MRA described
above and with which it was alternated.
Treatment
Once baseline MRAs were completed, 37.5 lg (1.25 mg/
kg) of Escherichia coli LPS (Serotype 0127:B8, Sigma, St
Louis, MO, USA) dissolved in 150 ll of 0.9% NaCl or an
equivalent volume of 0.9% NaCl vehicle was injected
intravenously (iv) over one minute. This dose of LPS is
more than ten times lower than the one needed to
induce 50% mortality within 72 h when given by the
same route (Eskandari et al., 1992). Indeed, 50 lg of
the same serotype of LPS injected intravenously does
not result in any mortality until 40 h after injection, but
does induce increases in circulating concentrations of
pro-inflammatory cytokines and apoptosis in gut epithe-
lium (Blank et al., 1997).
Tissue preparation
Two and a half hours after injection, and upon completion
of the last MRA sequence, animals were removed from
the magnet and injected with sodium pentobarbital
(0.3 ml of 550 mg/ml) while still under isoflurane
anesthesia. Once the hind paw reflex upon plantar
pinching had disappeared, the thoracic cage was
opened to allow for placement of a needle into the left
cardiac ventricle after the right atrium was cut. The
circulatory system of animals was next rinsed with
phosphate-buﬀered saline (PBS) after which brains of
that half of the animals allocated to polymerase chain
reaction (PCR) experiments were removed within two
minutes, frozen on crushed dry ice and stocked at
"80 "C while the remaining mice assigned to
immunohistochemical analyses were perfused with 4%
paraformaldehyde in 0.1 M PBS. After removal of these
perfusion-fixed brains, they were post-fixed for 4 h,
cryoprotected in 30% sucrose, frozen on dry ice and
stocked at "80 "C.
Real-time PCR
After RNAwas extracted and reverse transcribed to cDNA,
real-time SYBR green-based comparative PCR was
performed using a previously established protocol and
set of primers (Pourtau et al., 2014). Expression of mRNA
coding for COX2, mPGES, iNOS and preproET-1 relative
to that of beta-actin was calculated as 2"DCT (Schmittgen
and Livak, 2008) and as fold change (Pfaﬄ et al., 2002).
Relative expressions of monocyte chemoattractant protein-
1 (MCP-1)/CCL2 and tumor necrosis factor-a (TNFa) were
used as positive controls.
Immunohistochemistry
Brains were cut on a cryostat into 30-lm-thick sections
that were collected in cold cryoprotectant (0.05 M
phosphate buﬀer, 20% glycerol and 30% ethylene
glycol) and stored at "20 "C until further processing.
After washing oﬀ the cryoprotectant solution,
immunohistochemical processing was performed on a
one in six series of free-floating sections using the strepta
vidin–biotin–immunoperoxidase technique (Konsman and
Blomqvist, 2005). Briefly, non-specific binding sites were
blocked by a 1-h incubation of sections in PBS, pH 7.4,
containing 0.3% Triton X-100 and 1.0% bovine albumin.
A rabbit antiserum recognizing the transcription factor
c-Fos (Sc-52, Santa Cruz Biotechnology, Heidelberg,
Germany; diluted 1:2000), amply characterized in the
past including by us (Konsman and Blomqvist, 2005;
Konsman et al., 2008), was used to study neuronal activa-
tion. A goat antiserum directed against the p65 subunit of
NF-jB (Sc-372, Santa Cruz Biotechnology, Heidelberg,
Germany; diluted 1:500), characterized previously
(Nadjar et al., 2003) was employed to assess pro-
inflammatory signaling. A goat antiserum recognizing
COX-2 (Sc-1747, Santa Cruz Biotechnology, Heidelberg,
Germany; diluted 1:500), employed by our team in the
past (Konsman et al., 2004) was utilized to identify
cerebral sites of prostaglandin synthesis. Moreover, the
c-Fos, COX-2 and NF-kappa-B antisera used in the pre-
sent work are part of the Journal of Comparative Neurol-
ogy antibody database that contains collected information
on the antibodies used for immunohistochemistry based
on that journal’s policy requiring rigorous characterization
for antibodies. A rabbit antiserum specific for nitrosylated
tyrosine residues (nitrotyrosine; Millipore, Fontenay sous
Bois, France, diluted 1:250) was used as readout for the
production of NO and peroxynitrite during inflammation.
Antisera were added at dilutions indicated to PBS, 0.3%
Triton X-100 and 1.0% bovine albumin. Sections were
incubated in antiserum-containing buﬀers overnight at
room temperature. After four rinses in PBS, sections were
treated for 30 min in 0.3% (v/v) hydrogen peroxide to
block endogenous peroxidases followed by rinses in
PBS. Sections were incubated for 2 h at room tempera-
ture with either biotinylated donkey anti-rabbit IgG (Amer-
sham, Les Ulis, France) or biotinylated rabbit anti-goat
IgG (Dako, Les Ulis, France) diluted 1:500 in PBS
containing 0.3% Triton X-100 and 1.0% bovine albumin
and stained using the ABC protocol (Vectastain Elite,
Vector Laboratories, Eurobio/Abcys, Les Ullis, France)
with nickel-enhanced diaminobenzidine as a chromagen.
Stained sections were observed on a microscope
(Leica DM5500B, Leica Microsystems, Wetzlar,
Germany) under bright field illumination and images
were captured by a high-resolution CCD video camera
image and stored on a personal computer. Image
editing software (Adobe Photoshop, Adobe Systems,
San Jose, CA, USA) was used to adjust contrast and
brightness only and to prepare microphotographs.
Sections were also examined under ultraviolet (UV) light
to distinguish between arteries and other vessel types.
Indeed, excitation in the UV range provokes an
autofluorescence of elastin in the wall of arteries,
whereas veins are less autofluorescent due to a
reduced amount of elastin (Kingsley et al., 2001;
Hernanz et al., 2004).
Data presentation and analysis
MRA data were expressed as means ± standard error of
the mean (SEM) of change relative to baseline over time
after injection. These data were analyzed both as area
under the curve (AUC) by Student-t tests with iv
treatment as a between factor and by analyses of
variance (ANOVA) with iv treatment as a between factor
and post-injection time as a within factor. Significant
eﬀects and interactions were further analyzed by the
Newman–Keuls post hoc test. The number of c-Fos-
immunoreactive cells was determined in at least two
sections of the ventromedial preoptic area, supraoptic
and paraventricular nuclei of the hypothalamus in each
animal and analyzed by a Mann–Whiney U test. Real-
time PCR data were expressed as 2"DCT and analyzed
by a one-way ANOVA (Schmittgen and Livak, 2008). In
case a significant diﬀerence was found, data were
expressed as fold change and analyzed using Pair-Wise
Fixed Reallocation Randomization Tests, which take into
account real amplification eﬃciencies (Pfaﬄ et al., 2002).
In all cases, a level of p< 0.05 was considered as statisti-
cally significant.
RESULTS
Iv LPS resulted in lower cerebral blood flow in the
circle of Willis and in the anterior cerebral arteries
3D time-resolved MRA. An example of time-resolved
3D MRA represented by sequential maximum intensity
projections and indicating the diﬀerent time intervals
(I1-7) is shown in Fig. 1A. The time-resolved 3D MRA
sequence used here previously has been used to
determine blood flow velocity in the mouse carotids to
be #25 cm/s (Miraux et al., 2006). For comparative pur-
poses, the fronts of bright blood voxels were determined
at 8, 16 and 24 ms on the maximum intensity projection
flatmaps, as these correspond to filling of the internal car-
otids during I1 and I2, which occurred in an almost
straight line in an approximately horizontal plane, to
estimate flow. As 19 voxels had appeared during the pro-
gression of the anterior front of filling of the internal caro-
tids between 8 and 24 ms along the z-axis, corresponding
to 19 ! 0.219 mm (voxel size of 219 lm in z taking into
consideration voxel spatial resolution and the field of
view) = 4.2 mm, this calculation yielded an estimate of
26.25 cm/s flow velocity for the internal carotids, which
is compatible with the values determined for the mouse
carotids in our previous work (Miraux et al., 2006).
The Student-t tests on AUC of data expressed as
changes relative to baseline showed no diﬀerences in
arterial flow between treatments during I1 and I2, which
corresponded to filling of the internal carotids and
basilar artery. However, the same analyses revealed
tendencies for lower flow during I3 corresponding to
filling of the circle of Willis formed by the continuation of
the internal carotids and the posterior communicating
artery (t1,14 = 1.98, p= 0.067) as well as during I4 all
through which the anterior and middle cerebral arteries
were filled (t1,14 = 1.92, p= 0.074) in mice that were
given LPS as compared to those that received its vehicle.
Since blood flow may increase with time of isoflurane
anesthesia (Sicard et al., 2003; Duong, 2007; Shin et al.,
2007), the relative number of voxels that appeared
between sequential images of the filling of the circle of
Willis were also analyzed by repeated-measures ANO-
VAs. These analyses indicated indeed significantly
increased flow over time after iv injection (F5,65 = 2.52:
p< 0.05), but no eﬀect of treatment during I1 (Fig. 1A),
that is during filling of the internal carotids upstream of
the circle of Willis and that of the basilar artery. With
respect to I3 (Fig. 1A) corresponding to filling of the lateral
parts of the circle of Willis, flow also increased signifi-
cantly with time of the experiment (F5,60 = 4.05:
p< 0.01). However, iv LPS treatment tended to result
in lower flow in these vessels as compared to iv adminis-
tration of saline (F1,12 = 4.34, p= 0.059; Fig. 1B). Since
a significant interaction occurred between time and treat-
ment for filling of these segments (F5,60 = 2.43:
p< 0.05), post hoc tests were performed. These indi-
cated that flow was significantly lower 80 min after iv
LPS injection as compared to administration of its vehicle
(LPS < Sal; p< 0.05; Fig. 1B). Analysis of flow during I4
(Fig. 1A), which corresponded to filling of the initial seg-
ments of the anterior and middle cerebral arteries (ACA
and MCA), showed that, in addition to the increase over
time (F5,65 = 4.02: p< 0.01), flow was lower in mice that
received iv LPS than in animals that were given saline iv
(F1,13 = 8.06, p< 0.05; Fig. 1C).
3D MRA. Given that iv LPS compared to iv saline
administration resulted in lower flow during the interval
corresponding to the filling of the first segments of the
ACA and MCA, blood flow in ROIs placed on these
arteries as well as on some of their up- and downstream
arteries were assessed using 3D MRA in coronally-
oriented virtual brain slices (Fig. 2A). The Student-t tests
on AUC of data expressed as changes relative to
baseline showed lower flow in the right ACA
(t1,15 = 2.47, p< 0.05) and the azygos pericallosal
artery (t1,15 = 3.12, p< 0.01) as well as a tendency for
lower flow in the left ACA (t1,15 = 1.96, p= 0.069) in mice
that were injected with LPS as compared to those that
were administered saline.
Since blood flow may increase with time of isoflurane
anesthesia (Sicard et al., 2003; Duong, 2007; Shin et al.,
2007), flow data obtained in ROIs placed on arteries were
also analyzed by repeated-measures ANOVAs. ANOVAs
with treatment as a between factor and time after injection
as a within subject factor indicated that blood flow was
lower in ROIs placed on the ACAs at the base of the brain
after iv LPS injection than after iv saline administration
(F1,15 = 6.08, p< 0.05 and F1,15 = 4.91, p< 0.05 for
the right and left ACA, respectively; Fig. 2C), whereas
flow in the internal carotids upstream of the circle of Willis
(Fig. 2B) and in the MCAs was not diﬀerent between treat-
ments, but did increase over time (F6,90 = 3.20, p< 0.01
and F6,90 = 3.27, p< 0.01 for right and left carotid,
respectively). When similar analyses were employed on
brain-irrigating arteries downstream of the ACA, iv LPS
injection was found to result in significantly lower blood
flow compared to iv saline administration in the azygos
pericallosal artery (F1,15 = 9.75, p< 0.01; Fig. 2E) while
flow globally significantly increased over time
(F6,90 = 3.20, p< 0.01). The anterior amygdaloid arter-
ies showed a tendency (F6,90 = 2.08, p= 0.063) and a
significant interaction (F6,90 = 2.36, p< 0.05) between
iv treatment and time after injection
for this vessel in the right and left
hemisphere, respectively. Post-hoc
tests did however not indicate any dif-
ferences between iv LPS and saline
treatments at the diﬀerent time points
after injection in this artery (Fig. 2D).
Iv LPS increased cerebral
expression of prostaglandin H2-
and E2-synthesizing enzymes
The assumptions for application of the
comparative CT method are that
amplification eﬃciencies of cDNAs of
genes of interest and that of cDNA
of the control gene are similar and
close to 1. In the present conditions
the eﬃciency of cDNA amplification
of the control actin was 0.9 and that
of genes of interest 0.98–1.06, a
diﬀerence that may aﬀect fold
changes of expression. The
expression of genes for which a one-
way ANOVA on 2"DCT data, the
calculation of which presupposes
amplification eﬃciencies close to 1
(Schmittgen and Livak, 2008), indi-
cated a significant diﬀerence were
therefore further analyzed using the
Relative Expression Software Tool
(REST) for group-wise comparison
and statistical analysis of relative
expression that takes into account real
amplification eﬃciencies (Pfaﬄ et al.,
2002).
Isoflurane anesthesia, like other anesthetics, has
been shown to exert anti-inflammatory eﬀects and to
attenuate LPS-induced TNFa expression in peripheral
tissues (de Rossi et al., 2004; Flondor et al., 2008).
Induction of classical inflammatory molecules in the
brain was therefore studied before addressing the eﬀect
of iv LPS on the cerebral expression of vasoactive
mediators. TNFa and MCP-1/CCL2 mRNAs in the brain
increase after peripheral administration of LPS in mice
(Laye´ et al., 1994; Reyes et al., 2003) and were there-
fore used as positive controls in the present study.
Analyses of 2"DCT and fold changes of MCP-1/CCL2
and TNFa mRNAs indicated significant increases 2.5 h
after iv LPS treatment with expressions being 4.0 and
12.4 times higher, respectively, as compared to adminis-
tration of its vehicle (Table 1). The iv LPS-induced
increase in TNFa mRNA under isoflurane anesthesia
found in the present study was larger than that reported
at a comparable time point after iv administration of a
similar dose of LPS, but under ketamine-medetomodine
anesthesia (Ruiz-Valdepenas et al., 2011). Thus, even
though isoflurane may exert anti-inflammatory eﬀects, it
seems less important than for some other types of anes-
thesia and still allows for the study of cerebral expression
of inflammatory mediators.
Fig. 1. Flow measurements in the mouse internal carotid arteries, circle of Willis, ACA and MCA
with time-resolved 3D TOF-MRA. The top part illustrates the filling of these diﬀerent arterial
segments over time by a maximum intensity projection of signal in the horizontal plane (A). The
relative number of voxels to have appeared during intervals I3 (B: 24–32 ms) and I4 (C: 32–40 ms)
at diﬀerent time points after iv LPS or saline injection are shown in graphs. I1-7: intervals between
sequential images. ACA: anterior cerebral artery, IC: internal carotid (upstream of and as part of
the circle of Willis), MCA: middle cerebral artery, PcomA: posterior communicating artery.
*p< 0.05. Group sizes Sal: n= 9–10; LPS: n= 9–10.
A one-way ANOVA on 2"DCT COX-2 mRNA data
indicated significantly higher expression after iv LPS
administration than after iv saline injection. REST analysis
confirmed this eﬀect and allowed to determine that COX-2
mRNA expression was 2.4 times higher in LPS-treated
mice than in animals that received saline (Table 1). A one-
way ANOVA on 2"DCT mPGES mRNA data indicated
significantly higher expression 2.5 h after iv LPS
administration as compared to iv saline injection (Table 1).
However, when taking into account real amplification
eﬃciencies in the REST analysis this eﬀect was reduced
to one at the limit of significancy with a 1.4 times higher
mPGES mRNA expression in LPS-treated mice than in
animals that were given saline
(Table 1). Analyses of 2"DCT and fold
change of preproET-1 and iNOS
mRNAs data did not reveal any
significant diﬀerences between LPS
and saline treatment 2.5 h after their
iv administration (Table 1).
Iv LPS-induced inflammatory
signaling and prostaglandin
synthesis did not occur in cerebral
arteries
c-Fos. The lower flow in the ACA
and in the internal carotids within the
circle of Willis of mice injected with
LPS as compared to those
administered saline may therefore be
related to diﬀerences in neuronal
activity in the cerebral territories
supplied by these arteries. As the
preoptic region and the supraoptic
and paraventricular nuclei of the
hypothalamus receive their blood
supply largely from the ACA and
internal carotids (Ambach and
Palkovits, 1974a,b; Ambach et al.,
1978), the neuronal activation marker
c-Fos was detected in these struc-
tures by immunohistochemistry and
compared between iv saline- and iv
LPS-injected animals. Although no
diﬀerences in the number of c-Fos-
immunoreactive cells were observed
between treatments in the ventrome-
dial preoptic area (saline: 15.5
± 8.2; LPS 20.4 ± 7.1; U= 4.0,
nsal = 3, nLPS = 4, p> 0.10) and
the supraoptic nucleus (saline: 8.3
± 2.4; LPS 11.9 ± 3.2; U= 6.0,
nsal = 4, nLPS = 4, p> 0.10), LPS
treatment was found to decrease the
number of c-Fos-positive cells in the
paraventricular nucleus of the
hypothalamus (saline: 73.3 ± 3.4;
LPS 41.3 ± 4.7; U= 0.0, nsal = 3,
nLPS = 3, p< 0.05).
NK-jB. In contrast to c-Fos
induction, the expression of which can be provoked by a
wide variety of stimuli, the nuclear translocation of
NF-jB occurs more specifically in response to
inflammatory stimuli, including LPS and pro-
inflammatory cytokines (D’Acquisto et al., 1997; Abate
et al., 1998). The overall pattern of NF-jB-
immunoreactivity in the brain obtained after iv LPS injec-
tion was very much reminiscent of that reported after sys-
temic administration of the pro-inflammatory cytokine
interleukin-1ß in mice (Nadjar et al., 2003). In particular,
the vasculature between the forebrain hemispheres
where the azygos pericallosal artery runs and that of the
Fig. 2. Flow estimation in the mouse internal carotid arteries, ACA, anterior amygdaloid artery and
azygos pericallosal artery with 3D TOF-MRA. The top part illustrates the levels at which ROIs were
placed to measure the mean intensity of voxels in these arteries (A). Plates from mouse brain atlas
(Paxinos and Franklin, 2001) indicate brain levels corresponding to the levels at which vessels
were analyzed (A). The relative intensity of voxels in the internal carotid arteries (B), ACA (C),
anterior amygdaloid artery (D) and azygos pericallosal artery (E) at diﬀerent time points after iv
LPS or saline injection are shown in graphs. ACA: anterior cerebral artery, Amy: amygdaloid
artery, Azy: azygos pericallosal artery, IC: internal carotid (upstream of and as part of the circle of
Willis). *p< 0.05, **p< 0.01. Group sizes Sal: n= 9–10; LPS: n= 9–10.
ventromedial forebrain meningeal surface containing the
preoptic and lateral hypothalamic arteries displayed NF-
jB-immunoreactivity after iv LPS injection (Fig. 3 left pan-
els). The choroid plexus showed an important concentra-
tion of round nuclear-like staining indicating nuclear
translocation of NF-jB after iv LPS administration that
was absent when the NF-jB antiserum was omitted (data
not shown). Even though the round nuclear labeling was
not observed in the absence of the NF-jB antiserum,
some cytoplasmatic staining was found. This indicates
that, in spite of the reported low cross reactivity with
immunoglobulins of other species, the secondary anti-
serum did recognize some endogenous mouse
immunoglobulins in the choroid plexus and meninges giv-
ing rise to some cytoplasmatic background staining. How-
ever, as only round nuclear-like labeling was taken into
account as proxy for nuclear translocation, the cytoplas-
matic background staining did generally not hinder
analysis.
Since blood flow was found to be lower in the lateral
parts of the circle of Willis formed by the internal
carotids and in the ACA as well as in some downstream
arteries, analyses were focused on these vascular
territories. In particular, the azygos pericallosal artery
and the preoptic and lateral hypothalamic arteries, which
receive their input from the ACA, as well as for the latter
from the MCA and internal carotids (Ambach et al.,
1978; Dorr et al., 2007), were studied. No or very light
nuclear NF-jB-immunoreactivity was seen in vessels of
saline-treated mice (Fig. 4A, E and I). Iv LPS treatment
resulted in nuclear NF-jB-immunoreactivity in meningeal
cells and presumable veins (Fig. 4C, G) as these did not
display autofluorescence under UV stimulation
(Fig. 4D, H). Although several preoptic and lateral
hypothalamic arteries, identified by their autofluorescent
walls (Fig. 3K, L) also showed some nuclear NK-jB-
immunoreactivity after iv LPS administration (Fig. 4J), this
was of less intensity and much less widespread than in
veins.
COX-2. Constitutive expression of COX-2 was
observed in neurons of the hippocampus, cerebral
cortex and cerebellum, as previously reported (Elmquist
et al., 1997; Konsman et al., 2004). The vasculature
between the forebrain hemispheres where the azygos
pericallosal artery runs and that of the ventromedial fore-
brain meningeal surface containing the preoptic and lat-
eral hypothalamic arteries showed COX-2-
immunoreactivity after iv LPS administration (Fig. 3 right
panels). No or very light disk-shaped endothelial COX-2-
immunoreactivity was seen in the vessels between the
two forebrain hemispheres of saline-treated mice
(Fig. 5A). In contrast, strong endothelial COX-2-
immunoreactivity with characteristic disk-shaped perinu-
clear labeling was observed in interhemsipheric vessels
of mice injected iv with LPS (Fig. 5C). Neither constitutive
neuronal nor LPS-induced vascular-associated labeling
was observed when the COX-2 antiserum was omitted
(data not shown). Since the vessels in which COX-2
was induced between the two hemispheres did not show
UV-induced autofluorescence (Fig. 5D), they were con-
sidered to be veins and venules. At the ventral surface
of the forebrain, several vessels were found to strongly
express COX-2 in the meninges of LPS-treated animals
(Fig. 5E). These vessels were identified as veins since
they did not display autofluorescence under UV stimula-
tion (Fig. 5F). When patterns of COX-2-immunoreactivity
Table 1. Eﬀects of iv LPS on cerebral expression of inflammation-inducible enzymes producing vasoactive mediators and cytokines
Gene 2"DCT (±SEM) ANOVA Fold change (Standard error) REST
COX-2 Sal: 3.73E"03 (±4.05E"04)
PS: 1.83E"02 (±2.57E"03)
LPS > Sal
p< 0.01
2.423 (1.109–5.690) LPS > Sal
p< 0.01
ET-1 Sal: 9.52E"02 (±3.33E"02
LPS: 1.03E"01 (±2.35E"02)
NS –
iNOS Sal: 1.27E"05 (±3.01E"06)
LPS: 1.24E"04 (±8.64E"05)
NS –
mPGES Sal: 1.64E"03 (±4.72E"05)
LPS: 3.72E"03 (±5.01E"04
LPS> Sal
p< 0.01
1.430 (0.639 – 3.104) LPS > Sal
p= 0.051
MCP-1/CCL2 Sal: 1.09E"03 (±3.79E"04)
LPS: 1.18E"02 (±3.91E"03)
LPS > Sal
p< 0.05
4.031 (1.283 – 19.950) LPS > Sal
p< 0.05
TNFa Sal: 4.10E"04 (±3.69E"04)
LPS: 3.67E"03 (±1.13E"03)
LPS > Sal
p< 0.05
12.382 (1.999 – 62.299) LPS > Sal
p< 0.01
Fig. 3. Photomicrographs illustrating immunoreactivity for the p65
NF-jB subunit (A, B, E and G) and COX-2 (C, D, F and H) between
brain hemispheres (A, B, C and D) and on the ventromedial surface of
the forebrain (E, F, G and H) 2.5 h after intravenous injection of
bacterial LPS in mice. Higher magnifications of these fields as well as
saline controls and identification of vessels are shown in Figs. 4 and
5. cc: corpus callosum. Arrow heads > and < indicate labeling.
in the ventral meninges were compared between mice
injected with saline and those that were administered
LPS, it turned out that many strongly COX-2-positive ves-
sels were found in proximity to vessels lacking clear label-
ing in both experimental conditions (Fig. 5G, I). In either
condition, preoptic and lateral hypothalamic arteries iden-
tified by their autofluorescent walls (Fig. 5H, J) failed to
show COX-2 immunoreactivity.
Nitrotyrosine. During inflammation, the production of
important quantities of NO often occurs in parallel with
that of reactive oxygen species and gives rise to the
formation peroxynitrite, which, in turn, rapidly reacts with
tyrosine residues to yield nitrotyrosine (Berg et al.,
2011). In the large vessels of the meninges, no clear dif-
ferences in nitrotyrosine immunoreactivity were found
between animals that received iv LPS 2.5 h earlier and
those that were given its saline vehicle (Fig. 6A, B). This
lack of diﬀerence between groups was not due to a tech-
nical failure since we were able to detect occasional
nitrotyrosine-immunoreactive vessels and perivascular
cells (Fig. 6C, D). Furthermore, neurons in the cerebellum
of a mouse euthanized immediately after intraperitoneal
injection of LPS were stained with our protocol (data not
shown). This finding is in accordance with previous obser-
vations in naı¨ve mice (Mehl et al., 1999; Rodrigo et al.,
2001). Moreover, these cerebellar neurons showed
increased nitrotyrosine-immunoreactivity in a mouse that
was allowed to survive 6 h after intraperitoneal injection
of LPS (10 lg corresponding to 300 lg/kg) (data not
shown). Finally, positive signals were obtained throughout
sections when they were artificially nitrosylated by incu-
bating them in 1 mM sodium nitrite- and 1 mM H2O2-
containing 0.1 M sodium acetate buﬀer (pH 5.0) for
20 min prior to the immunohistochemistry protocol (data
not shown).
DISCUSSION
Time-resolved TOF MRA revealed no diﬀerences in blood
flow in the internal carotids upstream of the circle of Willis,
but indicated lower flow in its lateral parts as well as in the
middle and anterior cerebral arteries after intravenous
LPS injection as compared to saline administration.
Intravenous LPS increased cerebral expression of COX-
2 and prostaglandin E synthase mRNAs, but this de
novo expression occurred in veins rather than in arteries.
The increase in blood flow in the circle of Willis and
brain irrigating arteries over time after iv saline
administration in control mice as shown by MRA in the
present work corroborates results of previous studies
measuring cerebral blood flow with arterial spin labeling
and laser speckle flowmetry in intact rodents under
isoflurane anesthesia (Sicard et al., 2003; Duong, 2007;
Shin et al., 2007). This isoflurane-induced rise in cerebral
blood flow is partly mediated by increased NO production
in the brain (McPherson et al., 1994; Kehl et al., 2002;
Sjakste et al., 2005). However, one needs to bear in mind
that other inhaled anesthetics, at the same level of anes-
thesia, increase cerebral blood flow even more
(Holmstrom and Akeson, 2005). Hence, given the neces-
sity for a stable level of anesthesia for the present exper-
iments, an informed choice in favor of isoflurane was
made in the present work.
The MRA findings obtained after iv LPS injection in
mice are in accordance with clinical observations and
expand experimental data. Indeed, clinical studies have
observed anatomical signs of vasospasms in proximate
branches of the ACA and MCA using MRA during
sepsis-associated encephalopathy (Bartynski et al.,
2006; Polito et al., 2013). Moreover, flow speed in the ter-
ritory of the MCA, as measured with transcranial Doppler,
is reduced after iv LPS administration in healthy volun-
teers (Brassard et al., 2012). However, no animal study
so far has studied blood flow in the ACA and MCA and
their proximate branches in experimental sepsis models.
We were able to show, using 3D MRA, that iv LPS
reduced flow in the ACA and one of its branches, the azy-
gos pericallosal artery. Our findings expand experimental
observations of increased resting blood flow velocity in
the sensory cortex and vasodilation of subpial third-
order arterioles and venules after iv administration of
comparable doses of LPS in mice (Rosengarten et al.,
2007, 2008; Ruiz-Valdepenas et al., 2011). This vasodi-
latation in arterioles downstream of the ACA and MCA
Fig. 4. Photomicrographs illustrating immunoreactivity for the p65
NF-jB subunit between forebrain hemispheres (A and C) and on the
ventral surface of the forebrain (E, G, I and J) 2.5 h after intravenous
injection of saline (A, E and I) or bacterial LPS (C, G and J) in mice.
Dark images show autofluorescent arteries under UV light stimulation
of the fields shown in bright field images immediately left or above
them. ox: optic chiasm. Arrow heads > and < indicate labeling.
*Arteries. Scale bars = 100 lm.
may represent a physiological response to the reduced
flow in these arteries after iv LPS administration. How-
ever, the finding that iv LPS decreases sensory
stimulation-evoked blood flow responses in the cortex
prior to, and, later on, in spite of, increased resting flow
velocity indicates dysfunctional neurovascular coupling
(Rosengarten et al., 2007) and may be explained by lower
flow in upstream cerebral arteries as observed in the pre-
sent work.
The time-resolved 3D MRA results obtained here also
expand clinical observations in that they allow for
quantitative measurements in high-flow systems and
may therefore reveal hypo- or dysfunction well before
anatomical signs of vasospasms would be visible on
routinely used clinical MRA. Thus, our findings indicate
that blood flow in the first segments of the mouse ACA
and MCA is lower after iv LPS injection as compared to
administration of its vehicle. Importantly, with time-
resolved 3D MRA we were also able to show that flow
in the carotid arteries downstream of the brain was not
diﬀerent between iv LPS and saline treatment. It was
only when the internal carotids become part of the circle
of Willis that flow turned out to be lower in iv LPS-
injected mice than in control animals. These are
important observations as they indicate that reduced
flow in the first segments of the ACA and MCA during
sepsis is not necessarily the consequence of systemic
hypotension during bacteremia, but rather due to altered
vasoregulation within the circle of Willis and in more
downstream brain-irrigating arteries.
To identify potential mechanisms underlying
decreased blood flow in the ACA and azygos
pericallosal artery, we assessed the cerebral
production of prostaglandins, NO and ET-1 as
vasoactive mediators. ET-1 can be produced by
cerebrovascular endothelial cells and is one of the
most potent vasoconstrictors of cerebral arteries
(Salom et al., 1995). Although peripheral administration
of LPS in rodent has been reported to increase prepro-
ET-1 mRNA in the frontal cortex (Shimojo et al., 2006),
no diﬀerences in whole-brain preproET-1 mRNA expres-
sion were observed between iv LPS- and saline-treated
mice in the present work. This apparent discrepancy
can be explained by the fact that contrary to the previ-
ously published study, cells present in the circulatory
system of the brain were rinsed with PBS in the present
work. Indeed, murine mononuclear leukocytes produce
prepro ET-1 mRNA in response to LPS (Wahl et al.,
2005) and human circulating monocytes of septic
patients contain significantly more ET-1 mRNA than
those of healthy controls (Ebihara et al., 1998). Since
the ACA and MCA as well as meningeal and pial arteries
express the endothelin A receptor (De Oliveira et al.,
1995; Pierre and Davenport, 1995; Hansen-Schwartz
et al., 2002), this raises the possibility that ET-1 pro-
duced by circulating monocytes may exert vasoconstric-
tive eﬀects on cerebral arteries during systemic
inflammation. This hypothesis may be tested by repeat-
ing the experiments described here in wild-type mice
Fig. 5. Photomicrographs illustrating the distribution of COX-2-ir
between forebrain hemispheres (A and C) and on the ventral surface
of the forebrain (E, G and I) 2.5 h after intravenous injection of saline
(A and G) or bacterial LPS (C, G and J) in mice. Dark images show
autofluorescent arteries under UV light stimulation of the fields shown
in bright field images immediately left of them. Arrow
heads > and < indicate labeling. *Arteries. Scale bars = 100 lm.
Fig. 6. Photomicrographs illustrating immunoreactivity for nitroty-
rosine on the ventral surface of the forebrain 2.5 h after intravenous
injection of saline (A) or bacterial LPS (B, C and D) in mice. ox: optic
chiasm. Arrow head > indicates labeling. Scale bars = 100 lm.
that have received bone marrow depletion followed by
transplantation with ET-1-deficient cells.
During systemic inflammation, the production of large
quantities of NO by iNOS often occurs in parallel with that
of reactive oxygen species and gives rise to the formation
peroxynitrite (Berg et al., 2011). This highly reactive mole-
cule can nitrosylate proteins and stimulate contraction of
smooth muscle cells of cerebral arteries (Elliott et al.,
1998). However, we found neither increased cerebral
iNOS mRNA expression nor evidence of nitrosylation of
tyrosine residues in brain arteries 2.5 h after iv LPS injec-
tion. The absence of increased iNOS mRNA expression
during the first hours after iv LPS administration may be
explained by its long induction time. In fact, only direct
injection of LPS into the brain seems to result in a slight
elevation of iNOS mRNA 2 h later (Okamoto et al.,
1998). Instead, it takes 6 h to observe a robust increase
in iNOS mRNA regardless of whether LPS was adminis-
tered intracerebrally or systemically (Wong et al., 1996;
Okamoto et al., 1998).
Although COX-2 within the context of inflammation is
best known as the form of COX that is inducible by
inflammatory mediators, it is important to point out that
COX-2 is constitutively present in neurons and involved
in the physiological coupling of neuronal activity and
local changes in cerebral blood flow (Stefanovic et al.,
2006). Our RT-PCR analyses showed that iv LPS
increased cerebral COX-2 mRNA expression to a similar
extent as previously reported under comparable experi-
mental conditions (Ruiz-Valdepenas et al., 2011). In addi-
tion to its proper biological eﬀects, COX-2-derived
prostaglandin H2 also constitutes an intermediate for the
production of other vasoactive prostaglandins. Interest-
ingly, we found that mPGES mRNA expression increased
to a lesser extent than COX-2 mRNA after iv LPS. This
diﬀerentially increased expression of COX-2 and mPGES
after iv LPS suggests that not all prostaglandin H2 pro-
duced will be immediately transformed into prostaglandin
E2 and that both mediators may potentially exert vasoac-
tive eﬀects.
To determine if de novo synthesis of prostaglandin-
synthesizing enzymes occurred in brain-irrigating
arteries, immunohistochemical detection of the
transcription factor NF-jB, essential for COX-2
transcription (D’Acquisto et al., 1997; Abate et al.,
1998), as well as of COX-2 was employed. We observed
that iv LPS treatment resulted in nuclear NF-jB-
immunoreactivity mostly in veins and to a much less
important extent in ACA-derived azygos pericallosal
artery and preoptic and lateral hypothalamic arteries in
the meninges. We have previously shown that LPS-
induced COX-2 expression does not occur in alkaline
phosphatase-positive arterioles of the brain parenchyma
(Konsman et al., 2004). However, this marker does not
label meningeal arteries. Since rodent cerebral arteries
rapidly respond to LPS in vitro by increasing COX-2
expression (Hernanz et al., 2004), we set out to determine
if meningeal arteries express COX-2 after iv LPS admin-
istration. In the present work, COX-2-immunoreactivity
was observed in medium-sized and large vessels, often
adjacent to arteries, but both in iv saline- and LPS-
treated animals, even though it tended to be stronger in
the latter. The presence of COX-2-immunoreactivity in
cerebral vessels, presumably veins, of saline-injected
rodents is in contrast to our previous findings obtained
in animals that had not undergone isoflurane anesthesia
(Konsman et al., 2004), but may represent a biological
response to isoflurane-induced reduction of cerebral pros-
taglandin E2 contents (Sato et al., 1995).
The absence of iv LPS-induced COX-2 expression in
ACA-derived arteries observed here expands previous
incidental mention of the lack of COX-2 expression in
arteries identified by Giemsa stain after iv LPS
administration (Elmquist et al., 1997). mPGES is found
in COX-2-positive vessels in the meninges and the brain
parenchyma after peripheral LPS administration, but also
seems to be absent from ‘‘artery-like” vessels, based on
morphological criteria (Yamagata et al., 2001; Eskilsson
et al., 2014). So even though prostaglandin H2, induces
vasoconstriction in cerebral arteries (Toda et al., 1988;
Davidge, 2001) and prostaglandin E2 promotes vasocon-
striction in cerebral arteries and cortical arterioles (Jadhav
et al., 2004; Dabertrand et al., 2013), their respective syn-
thesizing enzymes are not induced in these vessels, but
rather in adjacent veins, during systemic inflammation.
Interestingly, systemic LPS administration also increases
blood-borne prostaglandin E2 (Tavares et al., 2006) and
prostaglandin E receptors in large cerebral arteries and
brain arterioles mediate vasoconstriction (Jadhav et al.,
2004; Dabertrand et al., 2013). It is therefore possible that
circulating, rather than locally produced, prostaglandin E2
mediates vasoconstrictive eﬀects on cerebral arteries dur-
ing systemic inflammation.
A rise in neuronal activity increases local as well as
more upstream pial arterial blood flow (Iadecola, 2004).
As the preoptic region and the supraoptic and paraventric-
ular nuclei of the hypothalamus receive their blood supply
largely from the ACA and internal carotids (Ambach and
Palkovits, 1974a,b; Ambach et al., 1978), important
changes in neuronal activity in these hypothalamic struc-
tures may have contributed to the diﬀerences in cerebral
blood flow in these vessels between systemic saline and
LPS administration. In the present work the number of
cells expressing the activation marker c-Fos was not dif-
ferent between treatments in these structures, except
for the paraventricular nucleus of the hypothalamus
(PVH) where LPS was found to reduce expression of this
cellular activation marker. These findings are at variance
with previous reports, including our own, showing
increased c-Fos expression in these rodent brain struc-
tures after systemic LPS administration in awake animals
(Konsman et al., 1999). Although the fact that LPS was
injected in anesthesized animals in the present work
may account for the absence of increased c-Fos expres-
sion in the ventromedian preoptic and supraoptic
hypothalamus, this cannot explain reduced cellular activa-
tion in the PVH. With respect to the latter finding it is
important to consider that, unlike in awake animals, c-
Fos expression in this structure was already abundant in
animals that received saline under isoflurane anesthesia.
Although, exposure to anesthesia maintaining concentra-
tions of isoflurane (0.6–1.5%) alone is not suﬃcient to
induce c-Fos expression in the PVH (Sawamura et al.,
2004), both exposure to magnetic fields and radiofrequen-
cies can increase c-Fos expression in the PVH (Ji et al.,
1998; Jorge-Mora et al., 2011). Since MRI involves both
exposure to a magnetic field and to various radio waves,
the high baseline c-Fos expression observed in the PVH
may be related to our methodological choices. The fact
that LPS then lowers PVH c-Fos expression in this con-
text may not necessarily be relevant to the pathophysiol-
ogy of sepsis and its complications. In addition, it is also
important to keep in mind that the PVH contains only
21.500 neurons and represents 0.36 mm3 (Kiss et al.,
1991) and thus constitutes less than 5% of the rodent
hypothalamus, which comprises about 10 mm3
(Bouilleret et al., 2009). It seems therefore unlikely that
the lower arterial cerebral blood flow in the ACA and inter-
nal carotids of LPS-treated mice compared to their saline-
injected controls was related to changes in neuronal activ-
ity in the hypothalamus.
CONCLUSION
Our work indicates that during LPS-induced systemic
inflammation no changes occur in the filling of the circle
of the Willis from the periphery, but that circulating LPS
alters outflow from the circle of Willis to the middle and
anterior cerebral arteries. These modifications in arterial
flow were not related to increased cerebral synthesis of
prostaglandins, but may be the consequence of the
action of circulating prostaglandins and other vasoactive
mediators on brain-irrigating arteries during systemic
inflammation.
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